ACE |
|
|
For the playing card, see Ace. For other meanings of the word ace, see Ace (disambiguation). ACE is a three-letter abbreviation which may refer to: Look up ACE in Wiktionary, the free dictionary. Accelerated Christian Education, a Bible-based educational curriculum for preschool through high school students. Accumulated cyclone energy, a measure used to express the activity of Atlantic hurricane seasons. ACE (file format), a data compression and archiving format. ACE (editor), a mult ...
Wikipedia - [full article]
ACE Clinical Trials
- Trial of ACE Inhibition in Children with Mitral Regurgitation after Repair of AVSD (A Trial Conducted by the Pediatric Heart Network)
ClinicalTrials.gov Identifier: NCT00113698 - Active, not recruiting
Defect, Congenital Heart; Heart Septal Defects, Ventricular; Heart Failure, Congestive
- Treatment of Immunoglobulin A (IgA) Nephropathy by Angiotensin-Converting Enzyme (ACE) Inhibitor
ClinicalTrials.gov Identifier: NCT00437463 - Active, not recruiting
Glomerulonephritis
- A Retrospective Analysis of the Use of ACE-Inhibitors and Angiotensin Receptor Blockers
ClinicalTrials.gov Identifier: NCT00321945 - Active, not recruiting
Atrial Fibrillation; Atrial Flutter
- High Dose Ace Inhibitor Therapy Versus Combination of ACE and ARB Therapy
ClinicalTrials.gov Identifier: NCT00212901 - Completed
Diabetic Kidney Disease
- Eplerenone, ACE Inhibition and Albuminuria
ClinicalTrials.gov Identifier: NCT00315016 - Recruiting
Diabetic Nephropathy
- The Fabrazyme® and Arbs and ACE Inhibitor Treatment (FAACET) Study
ClinicalTrials.gov Identifier: NCT00446862 - Recruiting
Fabry Disease; Proteinuria
- Effectiveness of Bradykinin Receptor Blocker at Reducing Swelling Associated With Angiotensin Converting Enzyme (ACE) Inhibitor-Associated Angioedema
ClinicalTrials.gov Identifier: NCT00517582 - Recruiting
Angioneurotic Edema
- Comparison Between Gamma 3 Nail and ACE Trochanteric Nail
ClinicalTrials.gov Identifier: NCT00367406 - Recruiting
Pertrochanteric and Subtrochanteric Femur Fractures
- Aging and Cancer Effects (ACE) Study
ClinicalTrials.gov Identifier: NCT00204880 - Recruiting
Breast Cancer; Lung Cancer
- Influence of Angiotensin Converting Enzyme (ACE) Genotype on Lung Diffusion in Heart Failure
ClinicalTrials.gov Identifier: NCT00361127 - Recruiting
Heart Failure, Congestive
- ACE Inhibition and Novel Cardiovascular Risk Factors
ClinicalTrials.gov Identifier: NCT00051389 - Active, not recruiting
Cardiovascular Diseases; Heart Diseases; Hypertension
- Effects of an Intensified Treatment With ACE-I,ATA II and Statins in Alport Syndrome
ClinicalTrials.gov Identifier: NCT00309257 - Recruiting
Alport Syndrome
- The Use of ACE Inhibitors in the Early Renal Post-Transplant Period
ClinicalTrials.gov Identifier: NCT00270153 - Recruiting
Renal Transplant Patients
- Trial of ACE Inhibition in Infants with Single Ventricle (A Trial Conducted by the Pediatric Heart Network)
ClinicalTrials.gov Identifier: NCT00113087 - Active, not recruiting
Defect, Congenital Heart; Heart Failure, Congestive
- ONTARGET: ONgoing Telmisartan Alone and in Combination with Ramipril Global Endpoint Tria Parallel Trial. TRANSCEND Telmisartan Randomized AssessmeNt Study in aCE iNtolerant Subjects with Cardiovascular Disease Trial.
ClinicalTrials.gov Identifier: NCT00153101 - Active, not recruiting
Cardiovascular Diseases
- Acute Haemodynamic Effects of Treatment With ACE-Inhibitores in Patients With Symptomatic Aortic Stenosis
ClinicalTrials.gov Identifier: NCT00252317 - Recruiting
Aortic Stenosis
- Stop Atherosclerosis in Native Diabetics Study (SANDS)
ClinicalTrials.gov Identifier: NCT00047424 - Active, not recruiting
Atherosclerosis; Cardiovascular Diseases; Heart Diseases; Diabetes Mellitus; Hypertension
- MATCHED (MC-1 and ACE Therapeutic Combination for Hypertensive Diabetics)
ClinicalTrials.gov Identifier: NCT00157729 - Completed
Diabetes Mellitus Type 2; Hypertension; Metabolic Syndrome
- Occluded Artery Trial (OAT)
ClinicalTrials.gov Identifier: NCT00004562 - Active, not recruiting
Cardiovascular Diseases; Heart Diseases; Myocardial Infarction; Heart Failure, Congestive; Heart Failure
- Electrophysiologic Effects of Late PCI (OAT-EP)
ClinicalTrials.gov Identifier: NCT00119847 - Active, not recruiting
Cardiovascular Diseases; Heart Diseases; Myocardial Infarction; Coronary Disease; Arrhythmia; Ventricular Fibrillation
- Antihypertensive and Lipid-Lowering Treatment to Prevent Heart Attack Trial (ALLHAT)
ClinicalTrials.gov Identifier: NCT00000542 - Active, not recruiting
Cardiovascular Diseases; Coronary Disease; Diabetes Mellitus; Heart Diseases; Hypercholesterolemia; Hypertension; Myocardial Infarction; ...
- ACE, Elective Abdominal Aortic Aneurysm – Open Versus Endovascular Repair
ClinicalTrials.gov Identifier: NCT00224718 - Recruiting
Elective Abdominal Aortic Aneurysm
- Renin-Angiogensin-Aldosterone System (RAAS), Inflammation, and Post-Operative Atrial Fibrillation
ClinicalTrials.gov Identifier: NCT00134862 - Recruiting
Cardiovascular Diseases; Heart Diseases; Arrhythmia
- Hypertension in Hemodialysis
ClinicalTrials.gov Identifier: NCT00067665 - Recruiting
Hypertension; hemodialysis; Left Ventricular Hypertrophy
- Rural Andhra Pradesh Cardiovascular Prevention Study (RAPCAPS)
ClinicalTrials.gov Identifier: NCT00263393 - Recruiting
* Myocardial Infarction; Angina Pectoris; Cerebrovascular Accidents; Diabetes Mellitus
- Treatment of High Blood Pressure Using Olmesartan with Hydrochlorothiazide Compared to an ACE Inhibitor with a Calcium Channel Blocker
ClinicalTrials.gov Identifier: NCT00185120 - Completed
Hypertension
- ACE Gene Polymorphism and ARDS Outcome
ClinicalTrials.gov Identifier: NCT00155779 - Completed
Adult Respiratory Distress Syndrome
- Maximal Dose of Angiotensin Converting Enzyme (ACE) Inhibitor for Treatment of Diabetic Kidney Disease
ClinicalTrials.gov Identifier: NCT00118976 - Completed
Diabetes Mellitus, Type I; Diabetic Nephropathy
- Racial Variation in ACE--Genetic and Physiologic Bases
ClinicalTrials.gov Identifier: NCT00005757 - Completed
Cardiovascular Diseases; Heart Diseases; Hypertension
- Long-Term Renoprotection of Optimal Antiproteinuric Doses of Benazepril and Losartan in Chronic Renal Insufficiency
ClinicalTrials.gov Identifier: NCT00338091 - Terminated
Renal Insufficiency,Chronic; Disease Progression; Proteinuria; Dose-Response Relationship,Drug; ACE Inhibitor; Angiotensin II Type 1 Receptor Blockers

Not Signed In -


